Jazz Pharmaceuticals market cap JAZZ

Share price times shares outstanding: what the whole company sells for, since 2011.

Jazz Pharmaceuticals is worth $13.9B at the close on Oct 23, 2026, at $214.00 a share.

That is up 65% over the last year and up 71% over five years.

Its highest close in our data was $16.7B in Aug 2026.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$13.9B	$9.8B	$16.7B	+34%
2025	$10.4B	$6B	$10.8B	+38%
2024	$7.5B	$6.4B	$8.3B	−3%
2023	$7.7B	$7.5B	$10B	−23%
2022	$10B	$8B	$10.3B	+28%
2021	$7.8B	$7.4B	$10.6B	−15%
2020	$9.2B	$5.4B	$9.2B	+8%
2019	$8.5B	$6.7B	$8.7B	+16%
2018	$7.3B	$7B	$10.7B	−9%
2017	$8.1B	$6.9B	$9.7B	+24%
2016	$6.5B	$6.1B	$9.6B	−24%
2015	$8.6B	$8.1B	$11.7B	−14%
2014	$10.1B	$7.3B	$10.8B	+41%
2013	$7.1B	$3.2B	$7.2B	+133%
2012	$3.1B	$1.9B	$3.4B	+88%
2011	$1.6B	$1.4B	$1.8B	n/a

Companies in Drug Manufacturers - General nearest Jazz Pharmaceuticals' size, closest first, today.

Company	Market cap
JAZZJazz Pharmaceuticals	$13.9B
BMRNBiomarin Pharmaceutical	$10.8B
CORTCorcept Therapeutics	$9.3B
PTGXProtagonist Therapeutics	$9B
TGTXTG Therapeutics	$8.3B
ALKSAlkermes plc.	$7.3B
AMRXAmneal Pharmaceuticals	$6.5B
LGNDLigand Pharmaceuticals	$6.1B
KNSAKiniksa Pharmaceuticals International	$6B
BIIBBiogen	$37B
INDVIndivior Pharmaceuticals	$4.1B
Peer median	$7.8B